Learn how Sally Ye, Sr. Scientist, DMPK, Boehringer Ingelheim Pharmaceuticals, Inc, reduced matrix interference in clinical ADA assays.View on demand
Using an affinity flow-through format, highly reproducible nanoliter microfluidics, and parallel processing, the Gyrolab platform transforms immunoassay workflows and shortens run times by automating assay steps, improving data quality.
Whether you’re looking for a complete system, a kit, or components, Gyrolab platforms miniaturize, integrate, and automate sample analysis at scale, maximizing your productivity and helping your lab make data-driven decisions – fast.
Our highly experienced scientists understand the best approaches to optimize your processes, remove obstacles to your work, and help you reach your goals faster.
Stay abreast of the latest scientific and technical developments impacting biopharmaceutical research.
Autoantibodies against type 1 interferons offer insight into severe COVID-19 cases in a recent groundbreaking study by Imagine Institute
Microsampling in preclinical and clinical biotherapeutic studies is matched with Gyrolab microfluidic bioanalytical techniques.
Gyrolab in-solution affinity analysis used to measure the low-picomolar dissociation constant of an Adnectin imaging ligand.
Accurate determination of high affinity is important when evaluating imaging ligands to monitor cancer immunotherapy.